Accessibility Menu
 
Arrow-Thin-Down
S&P 500
7,137.90
+1.0%
+73.89
Arrow-Thin-Down
DJI
49,490.03
+0.7%
+340.65
Arrow-Thin-Down
NASDAQ
24,657.57
+1.6%
+397.60
Arrow-Thin-Down
Bitcoin
$77,656.00
-0.4%
-$333.01
Arrow-Thin-Down
AAPL
$273.13
+2.6%
+$6.96
Arrow-Thin-Down
AMZN
$255.34
+2.2%
+$5.43
Arrow-Thin-Down
GOOG
$337.80
+2.2%
+$7.33
Arrow-Thin-Down
META
$674.72
+0.9%
+$5.88
Arrow-Thin-Down
MSFT
$432.85
+2.0%
+$8.69
Arrow-Thin-Down
NVDA
$202.34
+1.2%
+$2.46
Arrow-Thin-Down
TSLA
$387.51
+0.3%
+$1.09
Most Active StocksDaily Stock GainersDaily Stock Losers

Radiopharm Theranostics

(NASDAQ) RADX

Current Price$4.64
Market Cap$54.82M
Since IPO (2024)-74%
5 YearN/A
1 Year+10%
1 Month+0%

Radiopharm Theranostics Financials at a Glance

Market Cap

$54.82M

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$-2.94

P/E Ratio

-1.58

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$4.64

Volume

178

Open

$4.64

Previous Close

$4.64

Daily Range

$4.64 - $4.64

52-Week Range

$3.62 - $16.25

RADX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Radiopharm Theranostics

Industry

Biotechnology

Sector

Health Care

CEO

Riccardo Canevari

Website

radiopharmtheranostics.com

Headquarters

Carlton, VIC 3053, AU

RADX Financials

Key Financial Metrics (TTM)

Gross Margin

1%

Operating Margin

-11%

Net Income Margin

-11%

Return on Equity

-86%

Return on Capital

-53%

Return on Assets

-44%

Earnings Yield

-63.29%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$54.82M

Shares Outstanding

11.81M

Volume

178

Short Interest

0.00%

Avg. Volume

162.56K

Financials (TTM)

Gross Profit

$39.28K

Operating Income

$38.17M

EBITDA

$38.17M

Operating Cash Flow

$36.65M

Capital Expenditure

$0.00

Free Cash Flow

$36.65M

Cash & ST Invst.

$29.12M

Total Debt

$0.00

Radiopharm Theranostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$54.82M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Net Cash

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NBYNovaBay Pharmaceuticals, Inc.
$1.88-3.59%
CYCNCyclerion Therapeutics, Inc.
$3.06+2.00%
BCLIBrainstorm Cell Therapeutics Inc.
$0.84-1.05%
IBOImpact BioMedical Inc.
$0.66-5.33%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.86-0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.93+0.00%
AKANAkanda
$10.21+2.14%
POETPoet Technologies
$12.74+0.24%

Questions About RADX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services